To see the role of Navak Guggulu and Kanchnar Guggulu orally in Medoja Granthi (Lipoma)
Phase 2
- Conditions
- Health Condition 1: D17- Benign lipomatous neoplasm
- Registration Number
- CTRI/2021/08/035761
- Lead Sponsor
- Patanjali Ayurvedic College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient willing to participate in clinical study.
Patient not taking any other medicines for Medoja granthi.
Site - Anywhere on the body
Size- between 1-75cc (volume)
Number- 1 to 5 in numbers.
Exclusion Criteria
Patient having Medoja Granthi with inflammation and hyperpigmentation.
Infected lipoma, calcified lipoma, Ulcerated lipoma, Malignant change(liposarcoma).
Intolerance to therapy.
Patients who are suffering from any other systemic disorders.
During clinical trial, if a patient develops any serious conditions which requires urgent treatment.
Pregnant women and lactating mothers.
If a patient his/herself wants to withdraw from the clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective Parameters- <br/ ><br>Pain <br/ ><br>Site <br/ ><br> <br/ ><br>Objective Parameters- <br/ ><br>Size <br/ ><br>NumberTimepoint: 1 month
- Secondary Outcome Measures
Name Time Method Subjective Parameters- <br/ ><br>Pain <br/ ><br>Site <br/ ><br> <br/ ><br>Objective Parameters- <br/ ><br>Size <br/ ><br>NumberTimepoint: 3 months